BINSA Act

(a) In general. Not later than 60 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the appropriate congressional committees a report assessing whether flows of the United States capital into the biotechnology sector of the People's Republic of China, including through licensing transactions with Chinese biotechnology firms, negatively affect the United States national security and military readiness.

(b) Form. The report required by subsection (a) shall be submitted in unclassified form but may include a classified annex.

(c) Appropriate congressional committees defined. In this section, the term appropriate congressional committees means—

(1) the Committee on Armed Services of the House of Representatives;

(2) the Committee on Financial Services of the House of Representatives;

(3) the Permanent Select Committee on Intelligence of the House of Representatives;

(4) the Select Committee on the Strategic Competition between the United States and the Chinese Communist Party of the House of Representatives;

(5) the Committee on Armed Services of the Senate;

(6) the Committee on Banking, Housing, and Urban Affairs of the Senate; and

(7) the Select Committee on Intelligence of the Senate.